Literature DB >> 17106702

Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND).

Eric Visser1, Ernst Postema, Otto Boerman, Jeroen Visschers, Wim Oyen, Frans Corstens.   

Abstract

PURPOSE: Internal radiation dose calculations are normally carried out using the Medical Internal Radiation Dose (MIRD) schema. This requires residence times of radiopharmaceutical activity and S-values for all organs of interest. Residence times can be obtained by quantitative nuclear imaging modalities. For dealing with S-values, the freeware packages MIRDOSE and, more recently, OLINDA/EXM are available. However, these software packages do not calculate residence times from image data. METHODS AND
RESULTS: For this purpose, we developed an IDL-based software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND). SPRIND allows reading and viewing of planar whole-body scintigrams. Organ and background regions of interest (ROIs) can be drawn and are automatically mirrored from the anterior to the posterior view. ROI statistics are used to obtain anterior-posterior averaged counts for each organ, corrected for background activity and attenuation. Residence times for each organ are calculated based on effective decay. The total body biological half-time is calculated for use in the voiding bladder model. Red bone marrow absorbed dose can be calculated using bone regions in the scintigrams or by a blood-derived method. Finally, the results are written to a file in MIRDOSE-OLINDA/EXM format. Using scintigrams in DICOM, the complete analysis is gamma camera vendor independent, and can be performed on any computer using an IDL virtual machine.
CONCLUSION: SPRIND is an easy-to-use software package for radiation dose assessment studies. It has made these studies less time consuming and less error prone.

Mesh:

Substances:

Year:  2006        PMID: 17106702     DOI: 10.1007/s00259-006-0226-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  16 in total

1.  A radionuclide therapy treatment planning and dose estimation system.

Authors:  A Liu; L E Williams; G Lopatin; D M Yamauchi; J Y Wong; A A Raubitschek
Journal:  J Nucl Med       Date:  1999-07       Impact factor: 10.057

2.  Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions.

Authors:  K F Eckerman; M G Stabin
Journal:  Health Phys       Date:  2000-02       Impact factor: 1.316

3.  MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.

Authors:  J A Siegel; S R Thomas; J B Stubbs; M G Stabin; M T Hays; K F Koral; J S Robertson; R W Howell; B W Wessels; D R Fisher; D A Weber; A B Brill
Journal:  J Nucl Med       Date:  1999-02       Impact factor: 10.057

4.  An activity quantification method based on registration of CT and whole-body scintillation camera images, with application to 131I.

Authors:  Katarina Sjögreen; Michael Ljungberg; Sven-Erik Strand
Journal:  J Nucl Med       Date:  2002-07       Impact factor: 10.057

5.  Red cell, plasma, and blood volume in the healthy women measured by radiochromium cell-labeling and hematocrit.

Authors:  E BROWN; J HOPPER; J L HODGES; B BRADLEY; R WENNESLAND; H YAMAUCHI
Journal:  J Clin Invest       Date:  1962-12       Impact factor: 14.808

6.  Red cell, plasma and blood volume in healthy men measured by radiochromium (Cr51) cell tagging and hematocrit: influence of age, somatotype and habits of physical activity on the variance after regression of volumes to height and weight combined.

Authors:  R WENNESLAND; E BROWN; J HOPPER; J L HODGES; O E GUTTENTAG; K G SCOTT; I N TUCKER; B BRADLEY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

7.  In vivo quantitation of lesion radioactivity using external counting methods.

Authors:  S R Thomas; H R Maxon; J G Kereiakes
Journal:  Med Phys       Date:  1976 Jul-Aug       Impact factor: 4.071

8.  Internal radionuclide therapy: The ULMDOS software for treatment planning.

Authors:  Gerhard Glatting; Michael Landmann; Thomas Kull; Arthur Wunderlich; Norbert M Blumstein; Andreas K Buck; Sven N Reske
Journal:  Med Phys       Date:  2005-07       Impact factor: 4.071

9.  Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body.

Authors:  S Shen; G L DeNardo; G Sgouros; R T O'Donnell; S J DeNardo
Journal:  J Nucl Med       Date:  1999-12       Impact factor: 10.057

10.  Bone marrow dosimetry for radioimmunotherapy: theoretical considerations.

Authors:  G Sgouros
Journal:  J Nucl Med       Date:  1993-04       Impact factor: 10.057

View more
  4 in total

1.  Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer.

Authors:  Rafke Schoffelen; Wietske Woliner-van der Weg; Eric P Visser; David M Goldenberg; Robert M Sharkey; William J McBride; Chien-Hsing Chang; Edmund A Rossi; Winette T A van der Graaf; Wim J G Oyen; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-19       Impact factor: 9.236

2.  Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin.

Authors:  Inge van der Kroon; Wietske Woliner-van der Weg; Maarten Brom; Lieke Joosten; Cathelijne Frielink; Mark W Konijnenberg; Eric P Visser; Martin Gotthardt
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

3.  Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy.

Authors:  Wietske Woliner-van der Weg; Rafke Schoffelen; Robert F Hobbs; Martin Gotthardt; David M Goldenberg; Robert M Sharkey; Cornelis H Slump; Winette Ta van der Graaf; Wim Jg Oyen; Otto C Boerman; George Sgouros; Eric P Visser
Journal:  EJNMMI Phys       Date:  2015-02-24

4.  In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [11C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates.

Authors:  J S Dileep Kumar; Bing Bai; Francesca Zanderigo; Christine DeLorenzo; Jaya Prabhakaran; Ramin V Parsey; J John Mann
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.